KINNATE BIOPHARMA INC's ticker is KNTE and the CUSIP is 49705R105. A total of 80 filers reported holding KINNATE BIOPHARMA INC in Q4 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.8%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 9,671,643 | $58,997,022 | 25.20% |
| Vida Ventures Advisors, LLC | 2,207,772 | $13,467,409 | 18.10% |
| Lynx1 Capital Management LP | 1,998,417 | $12,190,344 | 10.54% |
| Nextech Invest Ltd. | 2,329,480 | $14,209,828 | 5.65% |
| Foresite Capital Management V, LLC | 875,001 | $5,337,506 | 4.15% |
| RA Capital Management | 4,264,144 | $26,011,278 | 0.53% |
| Orbimed Advisors | 4,043,629 | $24,666,137 | 0.47% |
| SVB FINANCIAL GROUP | 23,382 | $142,630 | 0.39% |
| HARVARD MANAGEMENT CO INC | 498,001 | $3,037,806 | 0.38% |
| Novo Holdings A/S | 815,707 | $4,975,813 | 0.31% |